Trials / Completed
CompletedNCT01335503
Effect of AN-PEP Enzyme on Gluten Digestion
Effect of AN-PEP Enzyme on Gastrointestinal Breakdown of Gluten
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- DSM Food Specialties · Industry
- Sex
- All
- Age
- 18 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
The aim is to demonstrate how fast and to what extent AN-PEP can degrade gluten in vivo in the stomach and how much gluten enters the small intestine. A second question is whether the caloric density of a meal can influence the efficacy of AN-PEP breakdown.
Detailed description
In this trial, the effect of AN-PEP enzyme on gastrointestinal breakdown of gluten will be investigated in healthy subjects. In addition, it will be assessed if meal calories can affect the efficacy of AN-PEP. Subjects receive intragastrically, either AN-PEP or placebo, with either a high or a low caloric meal in a double-blind, randomized, placebo-controlled, cross-over fashion. Gastrointestinal fluid will be sampled to measure breakdown of gluten.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | AN-PEP | Endoprotease enzyme (AN-PEP) |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2011-04-14
- Last updated
- 2013-08-13
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01335503. Inclusion in this directory is not an endorsement.